Profit Or Loss [Abstract]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Other income
1 326 EUR
30 998 EUR
4 180 EUR
Profit (loss) from operating activities
23 660 EUR
2 796 EUR
56 515 EUR
Finance income
474,000 EUR
4 453 EUR
5 422 EUR
Finance costs
511,000 EUR
1 364 EUR
2 702 EUR
Tax expense (income)
208,000 EUR
521,000 EUR
2,000 EUR
Profit (loss)
23 488 EUR
23 488 EUR
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
500.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
7.00
2,271.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.